🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an efficacy and safety study of ertugliflozin in participants with ...
Status
Completed
Location
Multiple Locations
Start Date
2013-12-13
Trial ID
NCT02033889
This is a study to evaluate the efficacy and safety of ertugliflozin (MK-88...
Status
Completed
Location
Multiple Locations
Start Date
2014-09-23
Trial ID
NCT02226003
Treatments Being Tested
This study will evaluate the efficacy and safety of ertugliflozin (MK-8835/...
Status
Completed
Location
Multiple Locations
Start Date
2013-12-02
Trial ID
NCT01986855
Treatments Being Tested
This study is to characterize the pharmacokinetics, safety, tolerability, a...
Status
Completed
Location
Multiple Locations
Start Date
2010-10
Trial ID
NCT01223339
Treatments Being Tested
Ertugliflozin (PF-04971729, MK-8835) is under development for the treatment...
Status
Completed
Location
Multiple Locations
Start Date
2009-12-14
Trial ID
NCT01018823
Treatments Being Tested
Open-label, prospective, single-arm, multicenter study to determine effects...
Status
Recruiting
Location
North west general hospital
Start Date
2023-03-01
Trial ID
NCT05644717
Treatments Being Tested
MK-8835-016 (B1521006) is designed to evaluate the safety and efficacy of a...
Status
Completed
Location
Multiple Locations
Start Date
2010-02-24
Trial ID
NCT01059825
The overall hypothesis is that treatment with the SGLT2 inhibitor Ertuglifl...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2023-02-02
Trial ID
NCT05152940
Treatments Being Tested
This is a safety and efficacy study of ertugliflozin (MK-8835/PF-04971729) ...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-12
Trial ID
NCT02036515
This is a study to evaluate the effect of renal impairment on the pharmacok...
Status
Completed
Location
Multiple Locations
Start Date
2013-10-01
Trial ID
NCT01948986
Treatments Being Tested